You must agree with the terms below to view. [I Agree]

General Terms of Use

By accessing and browsing Healing Light Seminars’ Bioelectromagnetic Research Library you accept, without limitation or qualification, the Terms of Use as outlined below and acknowledge full and complete acceptance of these terms. Please review the following terms carefully. If you do not agree to these terms, you should not use the Bioelectromagnetic Research Library.

Terms and Conditions

  1. Copying or redistribution of any portion of the Bioelectromagnetic Research Library in any manner for personal gain or commercial use, including commercial publication, or as a component of any internet, intranet or extranet database, information storage and retrieval system, or other compilation in any media by any means now or in the future is strictly prohibited.

  2. Users may download these files for their personal use subject to the limitations of fair use as defined in the United States copyright laws and any additional terms or restrictions which may apply. You are granted a non-exclusive, non-transferable, revocable license to access and use material strictly in accordance with this Agreement, solely for internal, personal, non-commercial purposes; and to print out discrete information solely for internal, personal, non-commercial purposes provided that you maintain all copyright and other policies contained therein.

  3. Any party wishing to use any of these files for any purpose other than the limited purposes identified above, must request and receive prior written approval from Healing Light Seminars and/or the copyright owner. Permission shall be granted on a case-by-case basis at the sole discretion of Healing Light Seminars and/or the copyright owner.

  4. This material is offered for educational purposes only. It is neither complete nor comprehensive for the conditions addressed, nor should it be relied on solely to propose a course of treatment for a particular individual nor used as a substitute for a consultation or advice from a qualified, medical or health professional. Healing Light Seminars, Inc. expressly disclaims any and all liability for any kind of loss or risk, personal or otherwise, which may be sustained as a result of the direct or indirect use of this material and makes no representations or warranties as to its accuracy or completeness.

  5. You agree to indemnify, defend and hold harmless Healing Light Seminars, its officers, employees and agents, from and against any and all claims, causes of action, allegations, costs, expenses, fees (including but not limited to reasonable attorney's fees), judgments, liabilities, losses and damages arising from or relating to your use of this information and website.

  1. Healing Light Seminars may at any time revise these Terms and Conditions by updating this posting. You are bound by any such revisions and should therefore periodically visit this page to review the then-current Terms and Conditions.

Digital Millenium Copyright Act (DMCA) Notices; Copyright Agent

Healing Light Seminars respects the intellectual property rights of others. If you believe that your work has been copied in a way that constitutes copyright infringement by any content or material in this Bioelectromagnetic Research Library, please provide the following information in writing to Healing Light Seminars Copyright Agent (see 17 U.S.C. Section 512(c)(3) for further details):

  1. A physical or electronic signature of a person authorized to act on behalf of the owner of the copyright.

  2. A description of the copyrighted work that you claim has been infringed.

  3. A description of the material that you claim to be infringing or to be the subject of infringing activity and that is to be removed or access to which is to be disabled, and information sufficient to permit us to locate the material.

  4. Information so that we can contact you, such as address, telephone number and e-mail address.

  5. A statement that you have a good faith belief that use of the material in the manner complained of is not authorized by the copyright owner, its agent, or the law.

  6. A statement that the information in the notification is accurate and, under penalty of perjury, that you are the copyright owner or are authorized to act on behalf of the owner of a copyright that is allegedly infringed.

Linking to the Bioelectromagnetic Research Library

You may be granted permission to provide links to the Laser Research Library at the discretion of Healing Light Seminars and upon its terms by requesting written permission by e-mail or letter in advance from us, provided (a) that you do not remove or obscure, by framing or otherwise, the copyright notice or any other content as displayed by us in the opening page and in the body of the Bioelectromagnetic Research Library, (b) your site does not engage in illegal, unethical or pornographic activities, and (c) you discontinue providing links to Healing Light Seminars Bioelectromagnetic Research Library immediately upon request by us.

I Agree with these terms.

I Agree with these terms.

Provided by www.HealingLightSeminars.com
Equipment, Education and Resources for Clinical Excellence in Energetic Therapies

I-ONE Therapy

BMC Musculoskelet Disord.  2012 Jun 6;13(1):88. [Epub ahead of print]

I-ONE therapy in patients undergoing total knee arthroplasty: a prospective, randomized and controlled study.

Moretti B, Notarnicola A, Moretti L, Setti S, De Terlizzi F, Pesce V, Patella V.

Abstract

BACKGROUND:

Total knee arthroplasty (TKA) is often associated with a severe local inflammatory reaction which, unless controlled, leads to persistent pain up to one year after surgery. Standard and accelerated rehabilitation protocols are currently being implemented after TKA, but no consensus exists regarding the long-term effects. Biophysical stimulation with pulsed electromagnetic fields (PEMFs) has been demonstrated to exert an anti-inflammatory effect, to promote early functional recovery and to maintain a positive long-term effect in patients undergoing joint arthroscopy. The aim of this study was to evaluate whether PEMFs can be used to limit the pain and enhance patient recovery after TKA.

METHODS:

A prospective, randomized, controlled study in 30 patients undergoing TKA was conducted. Patients were randomized into experimental PEMFs or a control group. Patients in the experimental group were instructed to use I-ONE stimulator 4hours/day for 60days. Postoperatively, all patients received the same rehabilitation program. Treatment outcome was assessed using the Knee Society Score, SF-36 Health-Survey and VAS. Patients were evaluated pre-operatively and one, two, six and 12 months after TKA. Joint swelling and Non Steroidal Anti Inflammatory Drug (NSAID) consumption were recorded. Comparisons between the two groups were carried out using a two-tail heteroschedastic Student’s t-test. Analysis of variance for each individual subject during the study was performed using ANOVA for multiple comparisons, applied on each group, and a Dunnet post hoc test. A p value<0.05 was considered statistically significant.

RESULTS:

Pre-operatively, no differences were observed between groups in terms of age, sex, weight, height, Knee-Score, VAS, SF-36 and joint swelling, with the exception of the Functional Score. The Knee-Score, SF-36 and VAS demonstrated significantly positive outcomes in the I-ONE stimulated group compared with the controls at follow-ups. In the I-ONE group, NSAID use was reduced and joint swelling resolution was more rapid than in controls. The effect of I-ONE therapy was maintained after use of the device was discontinued.

CONCLUSIONS:

The results of the study show early functional recovery in the I-ONE group. I-ONE therapy should be considered after TKA to prevent the inflammatory reaction elicited by surgery, for pain relief and to speed functional recovery.

Knee Surg Sports Traumatol Arthrosc.  2008 Jun;16(6):595-601. Epub 2008 Apr 2.

Effects of biophysical stimulation in patients undergoing arthroscopic reconstruction of anterior cruciate ligament: prospective, randomized and double blind study.

Benazzo F, Zanon G, Pederzini L, Modonesi F, Cardile C, Falez F, Ciolli L, La Cava F, Giannini S, Buda R, Setti S, Caruso G, Massari L.

Source

IRCCS Foundation, Orthopaedic and Traumatology Department, S. Matteo Hospital Institute, University of Pavia, Pavia, Italy.

Abstract

Pre-clinical studies have shown that treatment by pulsed electromagnetic fields (PEMFs) can limit the catabolic effects of pro-inflammatory cytokines on articular cartilage and favour the anabolic activity of the chondrocytes. Anterior cruciate ligament (ACL) reconstruction is usually performed by arthroscopic procedure that, even if minimally invasive, may elicit an inflammatory joint reaction detrimental to articular cartilage. In this study the effect of I-ONE PEMFs treatment in patients undergoing ACL reconstruction was investigated. The study end-points were (1) evaluation of patients’ functional recovery by International Knee Documentation Committee (IKDC) Form; (2) use of non-steroidal anti-inflammatory drugs (NSAIDs), necessary to control joint pain and inflammation. The study design was prospective, randomized and double blind. Sixty-nine patients were included in the study at baseline. Follow-up visits were scheduled at 30, 60 and 180 days, followed by 2-year follow-up interview. Patients were evaluated by IKDC Form and were asked to report on the use of NSAIDs. Patients were randomized to active or placebo treatments; active device generated a magnetic field of 1.5 mT at 75 Hz. Patients were instructed to use the stimulator (I-ONE) for 4 h per day for 60 days. All patients underwent ACL reconstruction with use of quadruple hamstrings semitendinosus and gracilis technique. At baseline there were no differences in the IKDC scores between the two groups. At follow-up visits the SF-36 Health Survey score showed a statistically significant faster recovery in the group of patients treated with I-ONE stimulator (P < 0.05). NSAIDs use was less frequent among active patients than controls (P < 0.05). Joint swelling resolution and return to normal range of motion occurred faster in the active treated group (P < 0.05) too. The 2-year follow-up did not shown statistically significant difference between the two groups. Furthermore for longitudinal analysis the generalized linear mixed effects model was applied to calculate the group x time interaction coefficient; this interaction showed a significant difference (P < 0.0001) between the active and placebo groups for all investigated variables: SF-36 Health Survey, IKDC Subjective Knee Evaluation and VAS. Twenty-nine patients (15 in the active group; 14 in the placebo group) underwent both ACL reconstruction and meniscectomy; when they were analysed separately the differences in SF-36 Health Survey scores between the two groups were larger then what observed in the whole study group (P < 0.05). The results of this study show that patient’s functional recovery occurs earlier in the active group. No side effects were observed and the treatment was well tolerated. The use of I-ONE should always be considered after ACL reconstruction, particularly in professional athletes, to shorten the recovery time, to limit joint inflammatory reaction and its catabolic effects on articular cartilage and ultimately for joint preservation.